Search results

EASI-KIDNEY Randomisation letter

EASI-KIDNEY GP run-in letter

Collaborators

Welcome

EASi-KIDNEY is an international, multi-centre, randomised double-blind placebo-controlled trial to assess whether in addition to standard care, the drug vicadrostat reduces the risk of kidney disease progression, hospitalisation for heart failure or death from cardiovascular disease in people with chronic kidney disease

EASi-KIDNEY video transcript

Dr Parminder Judge, Co-Principal Investigator, EASi-KIDNEY summarises what the trial's objective is

Complaints

Contact information

Who is responsible for and has access to my data during the study?

Who is responsible for my data?

Will data about me be shared during the study?

What are my data protection rights?

How will data about me be collected if I decide to join the study?

What are my rights?

How will the EASi-KIDNEY team keep my data safe during the study?

How long will my data be kept if I join the study?

Other medications

Contact information

Study treatment delivery

EASi-KIDNEY visits when study pills are issued

Initial 'run-in' phase